Evidence map›Paper›PMID 11290568›Full record

ArticleThe American journal of pathology2001

Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation.

B Qiu, K A Frait, F Reich, E Komuniecki, S W Chensue

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. The Role of CD4Frontiers in public health · 2022
    Article
  3. Cell Biology of Intracellular Adaptation ofMicrobiology spectrum · 2019
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors.American journal of physiology. Lung cellular and molecular physiology · 2013
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

B QiuDepartments of Pathology and Laboratory Medicine, Veterans Affairs Medical Center, 2215 Fuller Rd., Ann Arbor, MI 48105, USA.
K A Frait
F Reich
E Komuniecki
S W Chensue
Veterans Health Administration · USAnn Arbor VA Medical Center · USDepartment of Veterans Affairs · AUUniversity of Michigan–Ann Arbor · US

Funding

Lung Immunopathology Training Stipend SupplementT32HL007517 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUKACS, NICHOLAS W · 1985 to 2022
$6.1M
CHEMOKINE RECEPTOR DYNAMICS IN GRANULOMA FORMATIONR01AI043460 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENSUE, STEPHEN W · 1998 to 2013
$2.3M
Chemokine Receptor Dynamics in Granuloma FormationR56AI043460 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENSUE, STEPHEN W · 2008 to 2008
$252k
NHLBI NIH HHS T32 HL007517NHLBI NIH HHS T32HL07517NIAID NIH HHS AI43460NIAID NIH HHS R01 AI043460NIAID NIH HHS R56 AI043460
6 · The paper itself

Abstract

Transcript expression of 24 chemokines (CKs) was examined throughout 8 days in mouse lungs with type-1 (Th1) or type-2 (Th2) cytokine-mediated granulomas induced by bead-immobilized mycobacterial purified protein derivative or Schistosoma mansoni egg antigens. Where possible, CK protein levels were also measured. In addition, we examined effects of in vivo cytokine depletions. Findings were as follows: 1) bead challenge induced increases in 18 of 24 CK transcripts with type-1 and type-2 responses displaying different patterns. CKs fell into four categories: a) type-1-dominant (gamma-interferon-inducible protein (IP-10), monokine induced by INF-gamma (MIG), macrophage inflammatory protein-2 (MIP-2), lipopolysaccharide-induced chemokine (LIX), rodent growth-related oncogene homologue (KP), macrophage inflammatory protein-1alpha (MIP-1alpha) and -1beta (MIP-1beta), lymphotactin), b) type-2-dominant (eotaxin, monocyte chemotactic protein-2 (MCP-2) and -3 (MCP-3), liver and activation-regulated chemokine (LARC), T cell activation protein-3 (TCA-3), c) type-1 and type-2 co-dominant (MCP-1, MCP-5, monocyte-derived chemokine (MDC), thymus and activation-related chemokine (TARC), C10), and d) constitutive (lungkine, secondary lymphoid-tissue chemokine (SLC), EBI1-ligand chemokine (ELC), fractalkine, macrophage inflammatory protein-1gamma (MIP1-gamma), and stromal cell derived factor-1alpha (SDF1-alpha). 2) CKs displayed characteristic temporal patterns. CXC (IP-10, MIG, MIP-2, LIX, KC) and certain CC (MCP-1, MCP-5, MIP-1alpha, MIP-1beta) CKs were produced maximally within 1 to 2 days. Others (MCP-2, MCP-3, eotaxin, lymphotactin, LARC, TCA-3) displayed peak expression later. 3) Interferon-gamma neutralization profoundly abrogated MIG, but had little effect on other CKs. Tumor necrosis factor-alpha neutralization caused up to 50% reduction in a range of CKs. These findings indicate that type-1 and type-2 granulomas display characteristic CK profiles with coordinated expression that is under cytokine-mediated regulation.

Indexed as

AnimalsAntigens, BacterialAntigens, HelminthCell DivisionCell MovementChemokinesCytokinesFemaleGranulomaLeukocytesLung DiseasesMiceMice, Inbred CBAMycobacteriumRNA, MessengerSchistosoma mansoniAntigens, BacterialAntigens, HelminthChemokinesCytokinesRNA, MessengerTuberculin

Identifiers

PMID11290568
PMCPMC1891908
OpenAlexW1967981628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.